Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is one of the most heterogeneous and aggressive tumours that exist. The median survival of diagnosed patients is limited. For all these reasons, it is necessary to develop new disease markers that allow guidelines for clinical action to improve the average survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Saez, Miguel A., Barquero-Pozanco, Ines, del Hierro-Marlasca, Laura, de Castro Martinez, Patricia, Romero-Bazán, Adoración, Alvarez-Mon, Miguel A., Monserrat, Jorge, García-Honduvilla, Natalio, Buján, Julia, Alvarez-Mon, Melchor, Guijarro, Luis G., Ortega, Miguel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029823/
https://www.ncbi.nlm.nih.gov/pubmed/35454771
http://dx.doi.org/10.3390/cancers14081866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029823/
https://www.ncbi.nlm.nih.gov/pubmed/35454771
http://dx.doi.org/10.3390/cancers14081866

Ejemplares similares